The Effects of Gastric Acid Suppression on the Colonic Microbiome

Trial Profile

The Effects of Gastric Acid Suppression on the Colonic Microbiome

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Apr 2015

At a glance

  • Drugs Omeprazole (Primary)
  • Indications Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Zollinger-Ellison syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 13 Apr 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 26 Mar 2014 Planned end date changed from 1 Jul 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.
    • 26 Mar 2014 Trial status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top